Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/IN/Fort Wayne
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Fort Wayne, IN

Studies commonly pay $75 to $4,500 per completed study

118 clinical trials are currently recruiting participants within 30 miles of Fort Wayne. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

118studies recruiting
2+research centers nearby
3condition categories
Live from the NIH registry

Studies recruiting near Fort Wayne right now

Top 25 of 118 recruiting studies, sorted by proximity — each links to its official registry page

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Phase 1 Interventional 694 participants sought
Fort Wayne Medical Oncology and Hematology, Inc /ID# 232593 — Fort Wayne, Indiana (3.0 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT05005403)

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Triple-Negative Breast Cancer Phase 3 Interventional 1,530 participants sought
Parkview Research Center at Parkview Regional Medical Center ( Site 0011) — Fort Wayne, Indiana (3.0 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06393374)

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Large B-cell Lymphoma Phase 2 Interventional 250 participants sought
Fort Wayne Medical Oncology and Hematology — Fort Wayne, Indiana (3.0 mi) · Sponsor: Allogene Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06500273)

Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy

Neoplasm, Colorectal, Cognitive Impairment N/A Observational 60 participants sought
Parkview Cancer Institute — Fort Wayne, Indiana (3.0 mi) · Sponsor: Joseph McCollom
See eligibility & contact on ClinicalTrials.gov (NCT05014399)

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer Phase 3 Interventional 1,160 participants sought
Research Site — Fort Wayne, Indiana (3.0 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06692738)

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 490 participants sought
Parkview Research Center /ID# 277651 — Fort Wayne, Indiana (3.0 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT07155187)

BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease

HR+/HER2- Breast Cancer Phase 3 Interventional 1,056 participants sought
Fort Wayne Medical Oncology and Hematology — Fort Wayne, Indiana (3.0 mi) · Sponsor: BeOne Medicines
See eligibility & contact on ClinicalTrials.gov (NCT07492641)

Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer

Locoregional Recurrence, Hormone Receptor-positive Breast Cancer Phase 2 Interventional 200 participants sought
Parkview Research Center — Fort Wayne, Indiana (3.0 mi) · Sponsor: Oana Danciu
See eligibility & contact on ClinicalTrials.gov (NCT05467891)

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

End Stage Kidney Disease Phase 2, Phase 3 Interventional 3,110 participants sought
NANI Research — Fort Wayne, Indiana (3.0 mi) · Sponsor: CSL Behring
See eligibility & contact on ClinicalTrials.gov (NCT05485961)

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic Phase 3 Interventional 735 participants sought
Fort Wayne Medical Oncology and Hematology ( Site 5444) — Fort Wayne, Indiana (3.0 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT05947851)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
Radiation Oncology Associates PC — Fort Wayne, Indiana (3.0 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT01810913)

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Melanoma Phase 3 Interventional 560 participants sought
Fort Wayne Medical Oncology and Hematology — Fort Wayne, Indiana (3.0 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06246916)

Proximal FEmur Reconstruction or Internal Fixation fOR Metastases (PERFORM) Trial

Metastatic Bone Disease N/A Interventional 334 participants sought
Parkview Packnett Family Cancer Institute — Fort Wayne, Indiana (3.0 mi) · Sponsor: Michelle Ghert, MD
See eligibility & contact on ClinicalTrials.gov (NCT06863129)

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

Viral Lung Infection and Acute Respiratory Failure Phase 3 Interventional 3,527 participants sought
Research Site — Fort Wayne, Indiana (3.0 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT05624450)

Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body

Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion N/A Observational 150 participants sought
Fort Wayne Medical Oncology Hematology — Fort Wayne, Indiana (3.0 mi) · Sponsor: Bayer
See eligibility & contact on ClinicalTrials.gov (NCT04142437)

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

Epithelial Ovarian Cancer Phase 3 Interventional 1,100 participants sought
Research Site — Fort Wayne, Indiana (3.0 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07218809)

A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma

Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma Phase 3 Interventional 49 participants sought
Study Site 101 — Fort Wayne, Indiana (3.0 mi) · Sponsor: Grifols Biologicals, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07582432)

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

Locally Advanced Cervical Adenocarcinoma, Locally Advanced Cervical Adenosquamous Carcinoma Phase 3 Interventional 336 participants sought
Parkview Regional Medical Center — Fort Wayne, Indiana (3.0 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07061977)

ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors

Non Small Cell Lung Cancer Phase 3 Interventional 630 participants sought
Fort Wayne Medical Oncology - 1133 — Fort Wayne, Indiana (3.0 mi) · Sponsor: OncoC4, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05671510)

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 1,200 participants sought
Parkview Research Center at Parkview Regional Medical Center ( Site 0002) — Fort Wayne, Indiana (3.0 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06136559)

The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study

Chemotherapy Induced Peripheral Neuropathy (CIPN) N/A Interventional 142 participants sought
Parkview Cancer Institute — Fort Wayne, Indiana (3.0 mi) · Sponsor: Luminate Medical, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07142304)

The Happy Families Project: Testing the Effectiveness of a Conflict Resolution Program for Families

Mental Health, Conflict N/A Interventional 1,800 participants sought
Fort Wayne Center for Children and Families — Fort Wayne, Indiana (3.0 mi) · Sponsor: University of Notre Dame
See eligibility & contact on ClinicalTrials.gov (NCT04980794)

A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures

Stereotypical Prolonged Seizures Phase 3 Interventional 350 participants sought
Ep0162 50504 — Fort Wayne, Indiana (3.0 mi) · Sponsor: UCB Biopharma SRL
See eligibility & contact on ClinicalTrials.gov (NCT05077904)
Actively enrolling

Studies you may be able to join near Fort Wayne

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Fort Wayne

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Salus Research

★ 5.0
1220 Medical Park Dr A, Fort Wayne, IN 46825
(260) 755-1099
"Best of everything! Ten stars out of five!!"
— Bruce Wilder, 5★

Avenues Recovery Center at Fort Wayne

★ 4.9 (957 reviews)
2626 Fairfield Ave, Fort Wayne, IN 46807
(260) 909-8343
"I chose Avenues Ft. Wayne and have not one time felt regret over the decision.<br>The beds here are comfortable.<br>The rooms and facilities are clea…"
— Jonathan Buuck, 5★

Clinical trials in Fort Wayne: what's recruiting

The Fort Wayne area currently has 118 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Fort Wayne, the most active research areas are:

  • Cancer & Oncology17 studies
  • Liver & Kidney2 studies
  • Lungs & Breathing1 studies

Every listing shows the study phase, the recruiting site and its distance from Fort Wayne, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Fort Wayne

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Fort Wayne participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Fort Wayne pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Fort Wayne?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
What is the difference between a research center and a hospital study in Fort Wayne?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Fort Wayne?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Fort Wayne.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Fort Wayne typically complete one or two studies per year.

Paid clinical trials near Fort Wayne

Other metros within reach

Elkhart, IN105 Kalamazoo, MI103 South Bend, IN105 Dayton, OH308 Indianapolis, IN921 Toledo, OH208 Lansing, MI175 Ann Arbor, MI1,171

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Fort Wayne Bladder Issues Due To Spinal Cord Injury in Fort Wayne All conditions

More of IN

Indianapolis921 Elkhart105 South Bend105 Evansville68 Lafayette36

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts